Back to top
more

Lannett Co Inc (LCI)

(Delayed Data from NYSE)

$4.43 USD

4.43
357,527

-0.02 (-0.45%)

Updated May 7, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (205 out of 254)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Lannett (LCI) Beats Q3 Earnings Estimates

Lannett (LCI) delivered earnings and revenue surprises of 140.00% and -2.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Lannett (LCI) Q3 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lannett (LCI) Meets Q2 Earnings Estimates

Lannett (LCI) delivered earnings and revenue surprises of 0.00% and 2.95%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Should Value Investors Consider Lannett Company (LCI) Now?

Let's see if Lannett Company (LCI) stock is a good choice for value-oriented investors right now from multiple angles.

Lannett (LCI) Q1 Earnings and Revenues Lag Estimates

Lannett (LCI) delivered earnings and revenue surprises of -45.45% and -2.63%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Lannett (LCI) Q1 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lannett (LCI) Q3 Earnings and Revenues Surpass Estimates

Lannett (LCI) delivered earnings and revenue surprises of 3.85% and 8.18%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Lannett (LCI) Q3 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sanofi to Withdraw Zantac After FDA Warns of Carcinogens

The FDA requests drugmakers to withdraw all ranitidine medications, which includes Sanofi's (SNY) popular heartburn drug Zantac, due to possible increase in risk of cancer.

Lannett (LCI) Q2 Earnings Meet Estimates

Lannett (LCI) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Lannett (LCI) Q2 Earnings Expected to Decline

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lannett (LCI) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Lannett (LCI) closed at $9.01, marking a -1.64% move from the previous day.

Implied Volatility Surging for Lannett (LCI) Stock Options

Investors need to pay close attention to Lannett (LCI) stock based on the movements in the options market lately.

Lannett (LCI) Beats Q1 Earnings and Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 4.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Prothena (PRTA) Reports Narrower-than-Expected Loss in Q3

Prothena (PRTA) posts a narrower Q3 loss while sales surpass estimates.

Mallinckrodt (MNK) Q3 Earnings Beat, Stock Down on Sales Miss

Mallinckrodt (MNK) misses on sales but beats on earnings in the third quarter of 2019.

Bausch (BHC) Beats on Q3 Earnings & Sales, Raises Guidance

Bausch (BHC) beats on sales and earnings in the third quarter and raises annual guidance.

Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y

Endo (ENDP) reports better-than-expected results for the third quarter as Xiaflex delivers a strong performance.

Lannett (LCI) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Lannett (LCI) closed at $11.88, marking a -1% move from the previous day.

Analysts Estimate Lannett (LCI) to Report a Decline in Earnings: What to Look Out for

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lannett (LCI) to Report Q1 Earnings: What's in the Cards?

Lannet's (LCI) fiscal first-quarter 2020 results are likely to reflect strong performance of its anti-psychosis and cardiovascular drugs.

Lannett (LCI) Outpaces Stock Market Gains: What You Should Know

Lannett (LCI) closed the most recent trading day at $12.26, moving +1.16% from the previous trading session.

Is Lannett Co (LCI) Stock Outpacing Its Medical Peers This Year?

Is (LCI) Outperforming Other Medical Stocks This Year?

Lannett (LCI) Dips More Than Broader Markets: What You Should Know

Lannett (LCI) closed at $11.73 in the latest trading session, marking a -1.84% move from the prior day.

The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet

The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet